Invention Grant
US07923467B2 Substituted pyrrole derivatives and their use as HMG-CO inhibitors
失效
取代的吡咯衍生物及其用作HMG-CO抑制剂
- Patent Title: Substituted pyrrole derivatives and their use as HMG-CO inhibitors
- Patent Title (中): 取代的吡咯衍生物及其用作HMG-CO抑制剂
-
Application No.: US10558859Application Date: 2004-05-28
-
Publication No.: US07923467B2Publication Date: 2011-04-12
- Inventor: Mohammad Salman , Jitendra Sattigeri , Yatendra Kumar , Ram Chander Aryan , Vikram Krishna Ramanathan , Anita Chugh
- Applicant: Mohammad Salman , Jitendra Sattigeri , Yatendra Kumar , Ram Chander Aryan , Vikram Krishna Ramanathan , Anita Chugh
- Applicant Address: IN New Delhi, Delhi
- Assignee: Ranbaxy Laboratories, Inc.
- Current Assignee: Ranbaxy Laboratories, Inc.
- Current Assignee Address: IN New Delhi, Delhi
- Agency: Sheridan Ross, P.C.
- International Application: PCT/IB2004/001761 WO 20040528
- International Announcement: WO2004/106299 WO 20041209
- Main IPC: C07D405/06
- IPC: C07D405/06 ; C07D207/337 ; A61K31/4025 ; A61K31/40
Abstract:
The present invention relates to substituted pyrrole derivatives, which can be used as 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. Compounds disclosed herein can function as cholesterol lowering agents and can be used for the treatment of cholesterol-related diseases and related symptoms. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and methods of treating cholesterol-related diseases and related symptoms.
Public/Granted literature
- US20100056602A1 Substituted Pyrrole Derivatives And Their Use As HMG-CO Inhibitors Public/Granted day:2010-03-04
Information query
